Fralick Celeste Rachelle
- SEC CIK
- 0001911051
No open-market purchases or sales filed in the past year.
Current role at each company
- AWHL Aspira Women's Health Inc.Directoras of Apr 1, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fralick Celeste Rachelle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 26, 2023 (view filing) | Jul 24 | 2 days | Fralick Celeste RachelleDirector | PPurchase | +754 | $3.98 | +$3.00K | +6.7%12.0K after | |
| Aug 29, 2022 (view filing) | Aug 25 | 4 days | Fralick Celeste RachelleDirector | PPurchase | +6.67K | – | – | +6.9%102.9K after | |
| Aug 29, 2022 (view filing) | Aug 25 | 4 days | Fralick Celeste RachelleDirector | PPurchaseCommon stock, par value $0.001 | +6.67K | – | – | –6.67K after | Derivative |